Alaa Elwan

1.1k citations

37 papers · 992 · h-index 18

Impact in

Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
Organic Chemistry top 5%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Quinazolinone synthesis and applications

Papers in

Organic Chemistry 25
- Synthesis and biological activity 20
- Synthesis and Biological Evaluation 10
- Quinazolinone synthesis and applications 4
Molecular Biology 22
- Angiogenesis and VEGF in Cancer 15
- PI3K/AKT/mTOR signaling in cancer 5
- Cancer therapeutics and mechanisms 4

Co-authors: Ibrahim H. Eissa (26 shared papers)Hazem Elkady (20 shared papers)Eslam B. Elkaeed (16 shared papers)Hazem A. Mahdy (15 shared papers)Mohammed S. Taghour (14 shared papers)Abdel‐Ghany A. El‐Helby (5 shared papers)Khaled El‐Adl (5 shared papers)Helmy Sakr (6 shared papers)
Journals: Journal of Enzyme Inhibition and Medicinal Chemistry (8 papers)RSC Advances (3 papers)Future Medicinal Chemistry (3 papers)Bioorganic Chemistry (2 papers)Molecules (2 papers)
Partner nations: Egypt Saudi Arabia Indonesia

In The Last Decade

Alaa Elwan

34 papers receiving 985 citations

Peers

Countries citing papers authored by Alaa Elwan

Since Specialization

Citations

This map shows the geographic impact of Alaa Elwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alaa Elwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alaa Elwan more than expected).

Fields of papers citing papers by Alaa Elwan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alaa Elwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alaa Elwan. The network helps show where Alaa Elwan may publish in the future.

Co-authors

The 25 scholars most cited alongside Alaa Elwan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alaa Elwan Line = papers co-authored together Alaa Elwan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies Journal of Enzyme Inhibition and Medicinal Chemistry ·Hazem Elkady, Alaa Elwan, Hesham A. El‐Mahdy, Ahmed S. Doghish, Ahmed Ismail, Mohammed S. Taghour, Eslam B. Elkaeed, Ibrahim H. Eissa, Mohammed A. Dahab, Hazem A. Mahdy, Mohamed M. Khalifa	2021	112
2	Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents Bioorganic Chemistry ·Souad A. El‐Metwally, Mohsen M. Abou-El-Regal, Ibrahim H. Eissa, Ahmed B. M. Mehany, Hazem A. Mahdy, Hazem Elkady, Alaa Elwan, Eslam B. Elkaeed	2021	104
3	Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers Journal of Enzyme Inhibition and Medicinal Chemistry ·Mohammed M. Alanazi, Ibrahim H. Eissa, Nawaf A. Alsaif, Ahmad J. Obaidullah, Wael A. Alanazi, Abdullah F. Alasmari, Hussam Albassam, Hazem Elkady, Alaa Elwan	2021	81
4	Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors Bioorganic Chemistry ·Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr, Alaa Elwan	2020	64
5	Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers Journal of Enzyme Inhibition and Medicinal Chemistry ·Nawaf A. Alsaif, Mohammed S. Taghour, Mohammed M. Alanazi, Ahmad J. Obaidullah, Abdulrahman A. Almehizia, Manal M. Alanazi, Saleh Aldawas, Alaa Elwan, Hazem Elkady	2021	57
6	Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation Molecules ·Alaa Elwan, Abdallah E. Abdallah, Hazem A. Mahdy, Mohammed A. Dahab, Mohammed S. Taghour, Eslam B. Elkaeed, Ahmed B. M. Mehany, Ahmed Nabeeh, Mohammed Adel, Aisha A. Alsfouk, Hazem Elkady, Ibrahim H. Eissa	2022	51
7	Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and in silico studies Journal of Enzyme Inhibition and Medicinal Chemistry ·Mohammed M. Alanazi, Alaa Elwan, Nawaf A. Alsaif, Ahmad J. Obaidullah, Hamad M. Alkahtani, Abdulrahman A. Almehizia, Sultan M. Alsubaie, Mohammed S. Taghour, Ibrahim H. Eissa	2021	45
8	[1,2,4]Triazolo[4,3-a]quinoxaline and [1,2,4]triazolo[4,3-a]quinoxaline-1-thiol-derived DNA intercalators: design, synthesis, molecular docking, in silico ADMET profiles and anti-proliferative evaluations New Journal of Chemistry ·Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr, Alaa Elwan	2020	45
9	A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease International Journal of Molecular Sciences ·Eslam B. Elkaeed, Ibrahim H. Eissa, Hazem Elkady, Ahmed Abdelalim, Ahmad M. Alqaisi, Aisha A. Alsfouk, Alaa Elwan, Ahmed M. Metwaly	2022	44
10	Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation Journal of Enzyme Inhibition and Medicinal Chemistry ·Mohammed S. Taghour, Hazem A. Mahdy, Maher H. Gomaa, Ahmed Aglan, Mahmoud Gomaa Eldeib, Alaa Elwan, Mohammed A. Dahab, Eslam B. Elkaeed, Aisha A. Alsfouk, Mohamed M. Khalifa, Ibrahim H. Eissa, Hazem Elkady	2022	43
11	Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studies Journal of Enzyme Inhibition and Medicinal Chemistry ·Reda G. Yousef, Alaa Elwan, Ibraheem M. M. Gobaara, Ahmed B. M. Mehany, Wagdy M. Eldehna, Souad A. El‐Metwally, Bshra A. Alsfouk, Eslam B. Elkaeed, Ahmed M. Metwaly, Ibrahim H. Eissa	2022	37
12	Design, molecular docking and synthesis of some novel 4-acetyl-1-substituted-3,4-dihydroquinoxalin-2(1H)-one derivatives for anticonvulsant evaluation as AMPA-receptor antagonists Medicinal Chemistry Research ·Abdel‐Ghany A. El‐Helby, Rezk R. Ayyad, Khaled El‐Adl, Helmy Sakr, Ashraf A. Abd-Elrahman, Ibrahim H. Eissa, Alaa Elwan	2016	29
13	Quinoxalin-2(1H)-one derived AMPA-receptor antagonists: Design, synthesis, molecular docking and anticonvulsant activity Medicinal Chemistry Research ·Abdel‐Ghany A. El‐Helby, Rezk R. Ayyad, Khaled El‐Adl, Alaa Elwan	2017	26
14	New Theobromine Derivatives Inhibiting VEGFR-2: Design, Synthesis, Antiproliferative, Docking and Molecular Dynamics Simulations Future Medicinal Chemistry ·Hazem A. Mahdy, Hazem Elkady, Mohammed S. Taghour, Alaa Elwan, Mohammed A. Dahab, Mohamed A. Elkady, Elsayed G.E. Elsakka, Eslam B. Elkaeed, Bshra A. Alsfouk, Ibrahim M. Ibrahim, Ibrahim H. Eissa, Ahmed M. Metwaly	2023	24
15	Targeting VEGFR‐2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies Archiv der Pharmazie ·Nawaf A. Alsaif, Hazem A. Mahdy, Mohammed M. Alanazi, Ahmad J. Obaidullah, Hamad M. Alkahtani, Abdullah M. Al‐Hossaini, Abdulrahman A. Al‐Mehizi, Alaa Elwan, Mohammed S. Taghour	2021	21
16	Design, synthesis and molecular docking of new [1,2,4] triazolo[4,3-a]quinoxaline derivatives as anticancer agents targeting VEGFR-2 kinase Molecular Diversity ·Nawaf A. Alsaif, Alaa Elwan, Mohammed M. Alanazi, Ahmad J. Obaidullah, Wael A. Alanazi, Abdullah F. Alasmari, Hussam Albassam, Hazem A. Mahdy, Mohammed S. Taghour	2021	20
17	Structure-Based Virtual Screening, Docking, ADMET, Molecular Dynamics, and MM-PBSA Calculations for the Discovery of Potential Natural SARS-CoV-2 Helicase Inhibitors from the Traditional Chinese Medicine Journal of Chemistry ·Ahmed M. Metwaly, Alaa Elwan, Abdul-Aziz M.M. El-Attar, Sara T. Al‐Rashood, Ibrahim H. Eissa	2022	19
18	Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2 Molecules ·Reda G. Yousef, Wagdy M. Eldehna, Alaa Elwan, Abdelaziz S. Abdelaziz, Ahmed B. M. Mehany, Ibraheem M. M. Gobaara, Bshra A. Alsfouk, Eslam B. Elkaeed, Ahmed M. Metwaly, Ibrahim H. Eissa	2022	17
19	Design, synthesis, molecular modeling and biological evaluation of novel Benzoxazole-Benzamide conjugates via a 2-Thioacetamido linker as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers Journal of Enzyme Inhibition and Medicinal Chemistry ·Ibrahim H. Eissa, Radwan El‐Haggar, Mohammed A. Dahab, Marwa F. Ahmed, Hazem A. Mahdy, Reem I. Alsantali, Alaa Elwan, Nicolas Masurier, Samar S. Fatahala	2022	17
20	New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies Computational Biology and Chemistry ·Hazem Elkady, Abdelrahman A. Abuelkhir, Mahmoud Rashed, Mohammed S. Taghour, Mohammed A. Dahab, Hazem A. Mahdy, Alaa Elwan, Hanan Al-Ghulikah, Eslam B. Elkaeed, Ibrahim M. Ibrahim, Dalal Z. Husein, Ahmed M. Metwaly, Ibrahim H. Eissa	2023	16

About Alaa Elwan

Alaa Elwan is a scholar working on Organic Chemistry, Molecular Biology, Toxicology, Oncology and Pathology and Forensic Medicine, having authored 37 papers that have together received 992 indexed citations. Recurring topics across this work include Synthesis and biological activity (20 papers), Angiogenesis and VEGF in Cancer (15 papers), Bioactive Compounds and Antitumor Agents (13 papers), Synthesis and Biological Evaluation (10 papers), Cancer Mechanisms and Therapy (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Quinazolinone synthesis and applications (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Toxicology (212 citations), Organic Chemistry (629 citations), Molecular Biology (545 citations), Computational Theory and Mathematics (111 citations) and Pathology and Forensic Medicine (125 citations). Alaa Elwan has collaborated with scholars based in Egypt, Saudi Arabia and Indonesia. Frequent co-authors include Ibrahim H. Eissa, Hazem Elkady, Eslam B. Elkaeed, Hazem A. Mahdy, Mohammed S. Taghour, Abdel‐Ghany A. El‐Helby, Khaled El‐Adl, Helmy Sakr, Mohammed A. Dahab and Mohammed M. Alanazi. Their work appears in journals such as Journal of Enzyme Inhibition and Medicinal Chemistry, RSC Advances, Future Medicinal Chemistry, Bioorganic Chemistry and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Alaa Elwan

Impact in

Papers in i

In The Last Decade

Alaa Elwan

Peers

Countries citing papers authored by Alaa Elwan

Fields of papers citing papers by Alaa Elwan

All Works

About Alaa Elwan

Explore authors with similar magnitude of impact

Papers in